Viewing Study NCT04359667


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-01-25 @ 1:15 AM
Study NCT ID: NCT04359667
Status: UNKNOWN
Last Update Posted: 2020-11-12
First Post: 2020-04-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab
Sponsor: University Hospital for Infectious Diseases, Croatia
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
None Severe Pneumonia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None severe pneumonia View
None Interleukin-6 View
None tocilizumab View